Metraipolis › archive › dc_3f1fd72061fa

Beta-Blockers as Potential Adjuvants in Melanoma Treatment — Europe PMC PMID:41304533

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41304533
DOI: 10.3390/toxics13110981
License (as archived): solo-consultazione
Archived: 2026-10-15T18:10:50.044Z
SHA-256 of the archived text: 6d5910e9d4229e251d09cbf608df20be95d79a527ab62e9882481733e102c98d
Stable URL of this page: https://metraipolis.com/documento/dc_3f1fd72061fa

How to cite

Beta-Blockers as Potential Adjuvants in Melanoma Treatment — Europe PMC PMID:41304533 — Europe PMC (en), https://europepmc.org/article/MED/41304533 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3f1fd72061fa (Metraipolis archive dc_3f1fd72061fa, sha256 6d5910e9d4229e251d09cbf608df20be95d79a527ab62e9882481733e102c98d)

BibTeX

@misc{dc3f1fd72061fa,
  title = {Beta-Blockers as Potential Adjuvants in Melanoma Treatment — Europe PMC PMID:41304533},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304533},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3f1fd72061fa; sha256 6d5910e9d4229e251d09cbf608df20be95d79a527ab62e9882481733e102c98d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304533. Agents can read the archived copy with the MCP tool read_document.